A Community and Hospital cAre Bundle to improve the medical treatment of cLaudIcation and critical limb iSchaemia. The CHABLIS study

niversity of Leicester0 sites120 target enrollmentJanuary 27, 2021

Overview

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/37881303/ (added 29/11/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36690397/ embedded qualitative feasibility results (added 29/11/2023) Preprint results see attached file ISRCTN13202085 preprint results.pdf (added 09/04/2024) 2024 Results article in https://doi.org/10.1186/s40814-024-01445-z, (added 09/04/2024)

Registry

who.int

Start Date

January 27, 2021

End Date

June 4, 2022

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

niversity of Leicester

•1\. Adult (\>18 years of age) patient with incapacitating intermittent claudication or chronic limb threatening ischaemia (Rutherford stages 3–6\)
•2\. Referred to secondary care, either in a clinic or for inpatient treatment
•3\. Willing and able to give written informed consent for participation in the study
•4\. Access to a telephone or computer with internet access (for those taking part in remote interviews/consensus meeting)
•Healthcare professionals:
•5\. Healthcare professionals who provide care to patients with have symptomatic peripheral arterial disease

•1\. Female participants who are pregnant, lactating or planning a pregnancy during the course of the study
•2\. Patients who do not have the capacity to consent for themselves
•3\. Patients with a life\-limiting condition whereby conservative management is most appropriate
•4\. Patients with asymptomatic peripheral arterial disease